2020 was a year like no other. Since March 2020 conferences and events have rightfully been cancelled or postponed across the world, including our Annual International CytoSorb Users Meeting. So we challenged ourselves to come up with something that could to some extend replace the live event.
Continue reading
According to the current definition, sepsis is a life-threatening organ dysfunction due to a dysregulated body response to an infection. This systemic infection can be caused by bacteria, fungi or even viruses.
Continue reading
In this study, clinical researchers at Maasstad Hospital and at Erasmus University Medical Center in Rotterdam, Netherlands conducted a retrospective evaluation of 116 patients with septic shock, who required vasopressors to increase their blood pressure, and renal replacement therapy (RRT) due to kidney failure.
Continue reading
Mr. Vincent Capponi, Chief Operating Officer of CytoSorbents stated, „I am happy to announce CytoSorbents successfully completed its CE Mark and ISO13485:2016 re-certification audits. These certificates cover CytoSorb and our new manufacturing facility commissioned in June 2018. The success of this renewal of the CE Mark and recent audit is a reflection of CytoSorbents‘ ongoing commitment to quality. I am very proud of our quality, manufacturing, and research teams that contributed to these accomplishments.“
Continue reading
CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using its CytoSorb® blood purification technology to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, expands CytoSorb distribution to Brazil, Colombia and Costa Rica, with Contatti Medical, Service & Medical Colombia, and Nutricare Costa Rica, respectively.
Continue reading
One day ahead of the 39th International Symposium of Intensive Care and Emergency Medicine (ISICEM), CytoSorbents invited for its 6th International CytoSorb Users Meeting at the Square Meeting Center in Brussels, Belgium.
Continue reading
Blood poisoning is one of the leading causes of death in Germany. The Bramscher Niels Stensen clinics are now working as one of the first homes in the region with a new method that helps fight blood poisoning as early as possible and save human lives.
Continue reading
Just prior to the 38th ISICEM conference, CytoSorbents held its 5th International CytoSorb Users Meeting, relocating to the larger ISICEM conference center from the Hotel Marivaux in years past, to accommodate nearly 150 participants from the growing global CytoSorb community, including physicians, partners, and distributors.
Continue reading
The Department of Anaesthesiology, Anesthesiological Intensive Care and Perioperative Pain Management under the direction of Privatdozent Dr. med. med. Gerd Albuszies, MBA in the GPR Clinic, is now using a new therapy method in the critical care unit of the GPR Clinic, which is used in a massive inflammatory reaction of the body (inflammatory cytokine release) in sepsis.
Continue reading
The 4th German-speaking CytoSorb user meeting 2017 took place on the eve of the 17th DIVI 2017 in Leipzig. An excellent speaker panel presented new data and insights on the following topics ..
Continue reading